Multiple pathogens in adult patients admitted with community-acquired pneumonia: a one year prospective study of 346 consecutive patients
about
Azithromycin for acute lower respiratory tract infectionsAzithromycin for acute lower respiratory tract infectionsAzithromycin for acute lower respiratory tract infectionsBTS Guidelines for the Management of Community Acquired Pneumonia in AdultsStudy of community acquired pneumonia aetiology (SCAPA) in adults admitted to hospital: implications for management guidelinesPolymicrobial community-acquired pneumonia: An emerging entityDiagnosis of pneumococcal pneumonia: current pitfalls and the way forwardGuidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and preventionFluoroquinolones in the management of community-acquired pneumonia in primary care.'Atypical pneumonia'. Why this term may be better left unsaid.Community-acquired pneumonia caused by carbapenem-resistant Streptococcus pneumoniae: re-examining its prevention and treatment.Efficacy and safety of moxifloxacin in community acquired pneumonia: a prospective, multicenter, observational study (CAPRIVI).Usefulness of PCR and antigen latex agglutination test with samples obtained by transthoracic needle aspiration for diagnosis of pneumococcal pneumonia.Relationship between capsular type, penicillin susceptibility, and virulence of human Streptococcus pneumoniae isolates in miceValidation of immune-complex enzyme immunoassays for diagnosis of pneumococcal pneumonia among adults in Kenya.Importance of atypical pathogens of community-acquired pneumonia.Detection of Streptococcus pneumoniae antigen in bronchoalveolar lavage fluid samples by a rapid immunochromatographic membrane assay.Do guidelines for community-acquired pneumonia improve the cost-effectiveness of hospital care?Impact of preceding respiratory viral infections on the clinical severity of patients with pneumococcal pneumonia.Impact of cethromycin (ABT-773) therapy on microbiological, histologic, immunologic, and respiratory indices in a murine model of Mycoplasma pneumoniae lower respiratory infection.Development of conventional and real-time nucleic acid sequence-based amplification assays for detection of Chlamydophila pneumoniae in respiratory specimens.Comparison between pathogen directed antibiotic treatment and empirical broad spectrum antibiotic treatment in patients with community acquired pneumonia: a prospective randomised study.Observations from a multicentre study on the use of the sputum specimen in patients hospitalized with community-acquired pneumonia.Respiratory Infections in the U.S. Military: Recent Experience and ControlCommunity-acquired polymicrobial pneumonia in the intensive care unit: aetiology and prognosis.Effectiveness of beta lactam antibiotics compared with antibiotics active against atypical pathogens in non-severe community acquired pneumonia: meta-analysis.Etiology of community-acquired pneumonia in a population-based study: link between etiology and patients characteristics, process-of-care, clinical evolution and outcomesMicrobial aetiologic agents associated with pneumonia in immunocompromised hosts.Thin-section CT findings of patients with acute Streptococcus pneumoniae pneumonia with and without concurrent infection.Pneumonia with serological evidence of acute infection with the Chlamydia-like microorganism "Z".Risk of ruling out severe acute respiratory syndrome by ruling in another diagnosis: variable incidence of atypical bacteria coinfection based on diagnostic assays.Efficacy of BAL5788, a prodrug of cephalosporin BAL9141, in a mouse model of acute pneumococcal pneumonia.The Fcgamma receptor IIA-R/R131 genotype is associated with severe sepsis in community-acquired pneumonia.Atypical pathogens as etiologic agents in hospitalized patients with community-acquired pneumonia in Korea: a prospective multi-center study.Novel targets in the management of pneumonia.Cost-effectiveness of Xpert® MTB/RIF for diagnosing pulmonary tuberculosis in the United States.The incidence and etiology of community-acquired pneumonia in fever outpatients.Aetiological diagnosis of community acquired pneumonia: utility of rapid microbiological methods with respect to disease severity.Emerging drugs for pneumococcal pneumonia.Comparative study of community-acquired pneumonia caused by Streptococcus pneumoniae, Legionella pneumophila or Chlamydia pneumoniae.
P2860
Q24187354-43D5ADC5-AD76-46B9-8DC6-3D3A8DC1DED9Q24242162-EF2218E5-3409-40EA-8E0D-9EF3305D7CD1Q24245859-117A78F5-C7FF-41AE-8AB3-F7FA8D8C9CE0Q24675547-2797C960-FA1C-4A0E-9D1A-1FF60732CCF7Q24679117-08CA76BB-7345-4A6E-80D0-C0484A35E0FDQ26780356-8A8B91F7-BE06-4610-B779-E2CE8C8C6C3AQ26865184-17BB9662-D2F5-461E-B7D3-51CB2147126EQ28201389-0A61F49F-CF6C-427A-BA99-0AA5EE5EE041Q30452249-2DE8DAA1-5801-4115-A073-6C484507DC21Q33605262-18E772A8-4135-4014-8858-BEEA983D623BQ33685738-D753294F-F92E-4A97-9FAA-A693A2109564Q33929402-324F34CC-DC87-4279-AA13-4A7CA49A26FCQ33959303-B5A238BC-A780-40A2-83A0-4D6A8448D256Q33979716-BBED0F71-9D7C-4694-8449-FA91F8F803E7Q33998117-87AC3C67-FFE1-4FA0-9C08-C3CC44371A59Q34030766-6B322D0A-672B-44B1-90A4-5A5460A01570Q34041916-7BED412C-2E5D-476E-8567-147B37D94923Q34169255-F4D2A9AD-93BC-4FEE-A9F5-71E698E6E3FDQ34274927-1EA641B4-0059-43C2-8985-5680762E6B28Q34335695-94F5D48E-8EF7-49F8-B6E6-B5B896AC723AQ34569173-A479075F-17EB-43E4-9B99-A518B56AAF7EQ35537868-2326B3B7-A378-4920-8375-AF9DC231C368Q35649730-02DAE0AA-79E0-4924-B649-5CB8B5ECBAA2Q35763405-02E63F21-25BB-4DEB-957B-40EC01A4A9D6Q35908097-58DA76B9-B531-4F81-ADCF-187C9B716F5EQ36026172-85A39860-FE6D-4DCE-A075-20DBAE2FD8A0Q36291044-7263A598-5DED-4CCA-826A-B8621B801BC7Q36398126-33CFA50A-65D1-4E1F-A140-1507250572D6Q36653281-397CCA4D-7E20-4C5B-8D57-A3D748543055Q36880132-AFD4419C-235B-4090-A49A-AA7D757C0189Q36883429-AD272346-B121-42C1-A7CB-C8E18FFD5936Q37119259-EEAA8429-C3C2-41B3-B392-7D245D9935BFQ37256117-329DEB98-2EA9-4D41-AB29-EE779616BDBAQ37313129-6E1A5BA5-74E2-4CE0-9607-E347B445A2C6Q37362652-79D11654-49B1-483C-8BB0-91952862BD44Q37478715-9A83FD9A-865D-4576-8428-E1A80C3B141EQ37847463-5B433BBD-8DAE-49F7-BE94-66D8C41174FAQ37859065-F3CAE534-6EEC-4A9B-B51E-991A26D02F08Q37864327-EBC24806-5DE6-42FB-A9F8-43B01F4F42A8Q37866691-24A0F42A-ADF4-430F-BE78-7CCB48411CAF
P2860
Multiple pathogens in adult patients admitted with community-acquired pneumonia: a one year prospective study of 346 consecutive patients
description
1996 nî lūn-bûn
@nan
1996 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
Multiple pathogens in adult pa ...... dy of 346 consecutive patients
@ast
Multiple pathogens in adult pa ...... dy of 346 consecutive patients
@en
Multiple pathogens in adult pa ...... dy of 346 consecutive patients
@nl
type
label
Multiple pathogens in adult pa ...... dy of 346 consecutive patients
@ast
Multiple pathogens in adult pa ...... dy of 346 consecutive patients
@en
Multiple pathogens in adult pa ...... dy of 346 consecutive patients
@nl
prefLabel
Multiple pathogens in adult pa ...... dy of 346 consecutive patients
@ast
Multiple pathogens in adult pa ...... dy of 346 consecutive patients
@en
Multiple pathogens in adult pa ...... dy of 346 consecutive patients
@nl
P2093
P2860
P356
P1433
P1476
Multiple pathogens in adult pa ...... dy of 346 consecutive patients
@en
P2093
D Lieberman
F Schlaeffer
M G Friedman
M Leiononen
O Horovitz
S Horowitz
P2860
P304
P356
10.1136/THX.51.2.179
P407
P577
1996-02-01T00:00:00Z